Mutations in genes on the nucleotide excision repair pathway are associated with diseases, such as xeroderma pigmentosum (XP), Cockayne syndrome (CS) and trichothiodystrophy (TTD), that involve skin cancer and developmental and neurological symptoms.
DNA damage in non-transcribed regions of the genome is recognized by the combined action of the DNA damage-binding 2 (DDB2) and XPC recognition proteins. Structural studies show that the binding mechanism does not depend on the chemical nature of the damaged bases but only on the loss of hydrogen bonding, which produces local single-stranded regions and the extrusion of the damage to an extrahelical position.
The repair of damage in transcriptionally active regions is faster than in non-transcribed regions and is associated with the functions of the CSA (also known as ERCC8) and CSB (also known as ERCC6) genes. Mutations in this pathway are associated with photosensitivity and neurodegeneration.
The neurodegeneration in patients with defective DNA repair is associated in part with internally generated DNA damage. One potential source is reactive oxygen released from mitochondria; other sources could be circulating steroids and other reactive metabolites.
Mutations in the XPD protein, which is a component of the TFIIH transcription factor, result in a complex set of diseases, including XP, TTD and XP combined with CS. The complexity is thought to arise because mutations affect different functions of XPD, such as the helicase activity, the stability of TFIIH and the interactions of XPD with other transcription factor components.
Mice with individual nucleotide excision repair genes knocked out or with specific mutations inserted display a cancer-prone phenotype but weakly display a neurological phenotype, unless combined transcription-coupled repair and global genomic repair crosses are made.
Mutations in genes on the nucleotide excision repair pathway are associated with diseases, such as xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy, that involve skin cancer and developmental and neurological symptoms. These mutations cause the defective repair of damaged DNA and increased transcription arrest but, except for skin cancer, the links between repair and disease have not been obvious. Widely different clinical syndromes seem to result from mutations in the same gene, even when the mutations result in complete loss of function. The mapping of mutations in recently solved protein structures has begun to clarify the links between the molecular defects and phenotypes, but the identification of additional sources of clinical variability is still necessary.
This is a preview of subscription content
Subscribe to Journal
Get full journal access for 1 year
only $4.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Cleaver, J. E. Cancer in xeroderma pigmentosum and related disorders of DNA repair. Nature Rev. Cancer 5, 564–573 (2005).
Hoeijmakers, J. H. Genome maintenance mechanisms for preventing cancer. Nature 411, 366–374 (2001). A thorough review of the major pathways of nucleotide and base excision repair and DNA strand break repair and their relationships to human disease.
De Weerd-Kastelein, E. A., Keijzer, W. & Bootsma, D. Genetic heterogeneity of xeroderma pigmentosum demonstrated by somatic cell hybridization. Nature New Biol. 238, 80–83 (1972).
Wood, R. D., Mitchell, M., Sgouros, J. & Lindahl, T. Human DNA repair genes. Science 291, 1284–1289 (2001).
Kraemer, K. H., Lee, M. M. & Scotto, J. Xeroderma pigmentosum. Cutaneous, ocular and neurological abnormalities in 830 published cases. Arch. Dermatol. 123, 241–250 (1987). This paper describes the time course of onset of clinical symptoms, including photosensitivity and cancer, in a large cohort of patients with XP. It clearly shows the early onset and increased level of skin cancer in most patients.
Cleaver, J. E. Defective repair replication in xeroderma pigmentosum. Nature 218, 652–656 (1968). This paper is the first report of repair deficiency in three patients with XP; one patient had severe skin cancer and the other two patients had additional neurological symptoms.
Thompson, L. H. in DNA Repair in Higher Eukaryotes Vol. 2 (eds Nickoloff, J. A. & Hoekstra, M.) 335–393 (Humana, Totowa, 1998).
Cleaver, J. E. & Revet, I. Clinical implications of the basic defects in Cockayne syndrome and xeroderma pigmentosum and the DNA lesions responsible for cancer, neurodegeneration and aging. Mech. Ageing Dev. 129, 492–497 (2008).
Johnson, R. E., Kondratick, C. M., Prakash, S. & Prakash, L. hRAD30 mutations in the variant form of xeroderma pigmentosum. Science 264, 263–265 (1999).
Masutani, C. et al. The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase η. Nature 399, 700–704 (1999).
Kraemer, K. H., Lee, M. M., Andrews, A. D. & Lambert, W. C. The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm. Arch. Dermatol. 130, 1018–1021 (1994).
Kleijer, W. J. et al. Incidence of DNA repair deficiency disorders in western Europe: xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy. DNA Repair (Amst.) 7, 744–750 (2008).
Nishigori, C., Moriwaki, S., Takebe, H., Tanaka, T. & Imamura, S. Gene alterations and clinical characteristics of xeroderma pigmentosum group A patients in Japan. Arch. Dermatol. 130, 191–197 (1994).
Cleaver, J. E. DNA repair deficiencies and cellular senescence are unrelated in xeroderma pigmentosum cell lines. Mech. Ageing Dev. 27, 189–196 (1984).
Kraemer, K. H., Lee, M. M. & Scotto, J. DNA repair protects against cutaneous and internal neoplasia: evidence from xeroderma pigmentosum. Carcinogenesis 5, 511–514 (1984).
Sollitto, R. B., Kraemer, K. H. & DiGiovanna, J. J. Normal vitamin D levels can be maintained despite rigorous photoprotection: six years' experience with xeroderma pigmentosum. J. Am. Acad. Dermatol. 37, 942–947 (1997).
Dixon, K. M. et al. Skin cancer prevention: a possible role of 1,25dihydroxyvitamin D3 and its analogs. J. Steroid Biochem. Mol. Biol. 97, 137–143 (2005).
Spina, C. S. et al. Vitamin D and cancer. Anticancer Res. 26, 2515–2524 (2006).
Wijnhoven, S. W., Hoogervorst, E. M., de Waard, H., van der Horst, G. T. & van Steeg, H. Tissue specific mutagenic and carcinogenic responses in NER defective mouse models. Mutat. Res. 614, 77–94 (2007).
Nance, M. A. & Berry, S. A. Cockayne syndrome: review of 140 cases. Am. J. Med. Genet. 42, 68–84 (1992). This paper is an extensive description of the skin, neurological and developmental abnormalities in a large cohort of patients with CS.
Colella, S. et al. Alterations in the CSB gene in three Italian patients with the severe form of Cockayne syndrome (CS) but without clinical photosensitivity. Hum. Mol. Genet. 8, 935–941 (1999).
Cleaver, J. E., Charles, W. C., McDowell, M., Karentz, D. & Thomas, G. H. in DNA Repair Mechanisms Vol. 35 (eds Bohr, V. A., Wasserman, K. & Kraemer, K. H.) 56–67 (Munksgaard, Copenhagen, 1992).
Fujiwara, Y., Ichihashi, M., Kano, Y., Goto, K. & Shimuzu, K. A new human photosensitive subject with a defect in the recovery of DNA synthesis after ultraviolet-light irradiation. J. Invest. Dermatol. 77, 256–263 (1981).
Itoh, T., Ono, T. & Yamaizumi, M. A new UV-sensitive syndrome not belonging to any complementation groups of xeroderma pigmentosum or Cockayne syndrome: siblings showing biochemical characteristics of Cockayne syndrome without typical clinical manifestations. Mutat. Res. 314, 233–248 (1994).
Itoh, T., Fujiwara, Y., Ono, T. & Yamaizumi, M. UVs syndrome, a new general category of photosensitive disorder with defective DNA repair, is distinct from xeroderma pigmentosum variant and rodent complementation group I. Am. J. Hum. Genet. 56, 1267–1276 (1995).
Gorodetsky, E., Calkins, S., Ahn, J. & Brooks, P. J. ATM, the Mre11/Rad50/Nbs1 complex, and topoisomerase I are concentrated in the nucleus of Purkinje neurons in the juvenile human brain. DNA Repair (Amst.) 6, 1698–1707 (2007).
Laposa, R. R., Huang, E. J. & Cleaver, J. E. Increased apoptosis, p53 up-regulation, and cerebellar neuronal degeneration in repair-deficient Cockayne syndrome mice. Proc. Natl Acad. Sci. USA 104, 1389–1394 (2007).
Mayne, L. V. & Lehmann, A. R. Failure of RNA synthesis to recover after UV irradiation: an early defect in cells from individuals with Cockayne's syndrome and xeroderma pigmentosum. Cancer Res. 42, 1473–1478 (1982).
Rapin, I. et al. Cockayne syndrome in adults: review with clinical and pathologic study of a new case. J. Child Neurol. 21, 991–1006 (2006).
Miyauchi, H. et al. Cockayne syndrome in two adult siblings. J. Am. Acad. Dermatol. 30, 329–335 (1994).
Itin, P. H., Sarasin, A. & Pittelkow, M. R. Trichothiodystrophy: update on the sulfur-deficient brittle hair syndromes. J. Am. Acad. Dermatol. 44, 891–920 (2001).
Liang, C. et al. Structural and molecular hair abnormalities in trichothiodystrophy. J. Invest. Dermatol. 126, 2210–2216 (2006).
Faghri, S., Tamura, D., Kraemer, K. H. & Digiovanna, J. J. Trichothiodystrophy: a systematic review of 112 published cases characterizes a wide spectrum of clinical manifestations. J. Med. Genet. 45, 609–621 (2008). This paper is an extensive description of the skin, neurological and developmental abnormalities in a large cohort of patients with TTD.
Broughton, B. C. et al. Relationship between pyrimidine dimers, 6–4 photoproducts, repair synthesis and cell survival: studies using cells from patients with trichothiodystrophy. Mutat. Res. 235, 33–40 (1990).
Ranish, J. A. et al. Identification of TFB5, a new component of general transcription and DNA repair factor IIH. Nature Genet. 36, 707–713 (2004).
Giglia-Mari, G. et al. A new, tenth subunit of TFIIH is responsible for the DNA repair syndrome trichothiodystrophy group A. Nature Genet. 36, 714–719 (2004).
Botta, E. et al. Mutations in the C7orf11 (TTDN1) gene in six nonphotosensitive trichothiodystrophy patients: no obvious genotype–phenotype relationships. Hum. Mutat. 28, 92–96 (2007).
de Boer, J. et al. A mouse model for the basal transcription/DNA repair syndrome trichothiodystrophy. Mol. Cell 1, 981–990 (1998).
de Boer, J., Donker, I., de Wit, J., Hoeijmakers, J. H. J. & Weeda, G. Disruption of the mouse xeroderma pigmentosum group D DNA repair/basal transcription gene results in preimplantation lethality. Cancer Res. 58, 89–94 (1998).
Karentz, D. & Cleaver, J. E. Excision repair in xeroderma pigmentosum group C but not group D is clustered in a small fraction of the total genome. Mutat. Res. 165, 165–174 (1986).
Scrima, A. et al. Structural basis of UV DNA-damage recognition by the DDB1–DDB2 complex. Cell 135, 1213–1223 (2009).
Zelle, B. & Lohman, P. H. Repair of UV-endonuclease-susceptible sites in the 7 complementation groups of xeroderma pigmentosum A through G. Mutat. Res. 62, 363–368 (1979).
Tang, J. & Chu, G. Xeroderma pigmentosum complementation group E and UV-damaged DNA-binding protein. DNA Repair 1, 601–616 (2002).
Cleaver, J. E., Feeney, L., Tang, J. Y. & Tuttle, P. Xeroderma pigmentosum group C in an isolated region of Guatemala. J. Invest. Dermatol. 127, 493–496 (2007).
Khan, S. G. et al. XPC initiation codon mutation in xeroderma pigmentosum patients with and without neurological symptoms. DNA Repair (Amst.) 8, 114–125 (2009).
Bernardes de Jesus, B. M., Bjørås, M., Coin, F. & Egly, J. M. Dissection of the molecular defects caused by pathogenic mutations in the DNA repair factor XPC. Mol. Cell. Biol. 28, 7225–7235 (2008).
Hananian, J. & Cleaver, J. E. Xeroderma pigmentosum exhibiting neurological disorders and systemic lupus erythematosus. Clin. Genet. 17, 39–45 (1980).
Chavanne, F. et al. Mutations in the XPC gene in families with xeroderma pigmentosum and consequences at the cell, protein, and transcript levels. Cancer Res. 60, 1974–1982 (2000).
Khan, S. G. et al. The human XPC DNA repair gene: arrangement, splice site information content and influence of a single nucleotide polymorphism in a splice acceptor site on alternative splicing and function. Nucleic Acids Res. 30, 3624–3631 (2002).
Khan, S. G. et al. Two essential splice lariat branchpoint sequences in one intron in a xeroderma pigmentosum DNA repair gene: mutations result in reduced XPC mRNA levels that correlate with cancer risk. Hum. Mol. Genet. 13, 343–352 (2004).
Emmert, S., Kobayashi, N., Khan, S. G. & Kraemer, K. H. The xeroderma pigmentosum group C gene leads to selective repair of cyclobutane pyrimidine dimers rather than 6–4 photoproducts. Proc. Natl Acad. Sci. USA 97, 2151–2156 (2000).
Bunick, C. G., Miller, M. R., Fuller, B. E., Fanning, E. & Chazin, W. J. Biochemical and structural domain analysis of xeroderma pigmentosum complementation group C protein. Biochemistry 45, 14965–14979 (2006).
Khan, S. G. et al. Reduced XPC DNA repair gene mRNA levels in clinically normal parents of xeroderma pigmentosum patients. Carcinogenesis 27, 84–94 (2006).
Melis, J. P. et al. Mouse models for xeroderma pigmentosum group A and group C show divergent cancer phenotypes. Cancer Res. 68, 1347–1353 (2008).
Yasuda, G. et al. In vivo destabilization and functional defects of the xeroderma pigmentosum C protein caused by a pathogenic missense mutation. Mol. Cell. Biol. 27, 6606–6614 (2007).
Maillard, O., Solyom, S. & Naegeli, H. An aromatic sensor with aversion to damaged strands confers versatility to DNA repair. PloS Biol. 5, e79 (2007).
Min, J. H. & Pavletich, N. P. Recognition of DNA damage by the Rad4 nucleotide excision repair protein. Nature 449, 570–575 (2007).
Sugasawa, K. et al. UV-induced ubiquitylation of XPC protein mediated by UV-DDB–ubiquitin ligase complex. Cell 121, 387–400 (2005).
Sugasawa, K. & Hanaoka, F. Sensing of DNA damage by XPC/Rad4: one protein for many lesions. Nature Struct. Mol. Biol. 14, 887–888 (2007).
Groisman, R. et al. The ubiquitin ligase activity in the DDB2 and CSA complexes is differentially regulated by the COP9 signalosome in response to DNA damage. Cell 113, 357–367 (2003).
Fousteri, M., Vermeulen, W., van Zeeland, A. A. & Mullenders, L. H. Cockayne syndrome A and B proteins differentially regulate recruitment of chromatin remodeling and repair factors to stalled RNA polymerase II in vivo. Mol. Cell 23, 471–482 (2006).
Bregman, D. B. et al. UV-induced ubiquitination of RNA polymerase II: a novel modification deficient in Cockayne syndrome cells. Proc. Natl Acad. Sci. USA 93, 11586–11590 (1996).
Svejstrup, J. Q. Rescue of arrested RNA polymerase II complexes. J. Cell Sci. 116, 447–451 (2003).
Tantin, D., Kansal, A. & Carey, M. Recruitment of the putative repair coupling factor CSB/ERCC6 to RNA polymerase elongation complex. Mol. Cell. Biol. 17, 6803–6814 (1997).
Lehmann, A. R., Kirk-Bell, S. & Mayne, L. Abnormal kinetics of DNA synthesis in ultraviolet light-irradiated cells from patients with Cockayne's syndrome. Cancer Res. 39, 4237–4241 (1979).
Licht, C. L., Stevnser, T. & Bohr, V. A. Cockayne syndrome group B cellular and biochemical functions. Am. J. Hum. Genet. 73, 1217–1239 (2003). This paper provides an extensive review of the cellular properties of CS cells in culture, including their sensitivity to DNA-damaging agents, repair deficiencies and protein interactions.
Ljungman, M. & Zhang, F. Blockage of RNA polymerase as a possible trigger for u.v. light-induced apoptosis. Oncogene 13, 823–831 (1996).
Parris, C. H. & Kraemer, K. H. Ultraviolet-light induced mutations in Cockayne syndrome cells are primarily caused by cyclobutane dimer photoproducts while repair of other photoproducts is normal. Proc. Natl Acad. Sci. USA 90, 7260–7264 (1993).
Yuan, X., Feng, W., Imhof, A., Grummt, I. & Zhou, Y. Activation of RNA polymerase I transcription by cockayne syndrome group B protein and histone methyltransferase G9a. Mol. Cell 27, 585–595 (2007).
Spivak, G. & Hanawalt, P. C. Host cell reactivation of plasmids containing oxidative DNA lesions is defective in Cockayne syndrome but normal in UV-sensitive syndrome fibroblasts. DNA Repair (Amst.) 5, 13–22 (2006).
Balajee, A. S., Dianova, I. & Bohr, V. A. Oxidative damage-induced PCNA complex formation is efficient in xeroderma pigmentosum group A but reduced in Cockayne syndrome group B cells. Nucleic Acids Res. 27, 4476–4482 (1999).
Frosina, G. Oxidatively damaged DNA repair defect in cockayne syndrome and its complementation by heterologous repair proteins. Curr. Med. Chem. 15, 940–953 (2008).
Tuo, J., Jaruga, P., Rodriguez, H., Bohr, V. A. & Dizdaroglu, M. Primary fibroblasts of Cockayne syndrome patients are defective in cellular repair of 8-hydroxyguanine and 8-hydroxyadenine resulting from oxidative stress. FASEB J. 17, 668–674 (2003).
Niedernhofer, L. J., Daniels, J. S., Rouzer, C. A., Greene, R. E. & Marnett, L. J. Malondialdehyde, a product of lipid peroxidation, is mutagenic in human cells. J. Biol. Chem. 278, 31426–31433 (2003).
Maddukuri, L. et al. Cockayne syndrome group B protein is engaged in processing of DNA adducts of lipid peroxidation product trans-4-hydroxy-2-nonenal. Mutat. Res. 666, 23–31 (2009).
de Waard, H. et al. Different effects of CSA and CSB deficiency on sensitivity to oxidative damage. Mol. Cell. Biol. 24, 7941–7948 (2004).
Kyng, K. J. et al. The transcriptional response after oxidative stress is defective in Cockayne syndrome group B cells. Oncogene 22, 1135–1149 (2003).
Hayashi, M., Araki, S., Kohyama, J., Shioda, K. & Fukatsu, R. Oxidative nucleotide damage and superoxide dismutase expression in the brains of xeroderma pigmentosum group A and Cockayne syndrome. Brain Dev. 27, 34–38 (2005).
Citterio, E. et al. Biochemical and biological characterization of wild-type and ATPase-deficient Cockayne syndrome B repair protein. J. Biol. Chem. 273, 11844–11851 (1998).
Selby, C. P. & Sancar, A. Human transcription-repair coupling factor CSB/ERCC6 is a DNA-stimulated ATPase but is not a helicase and does not disrupt the ternary transcription complex of stalled RNA polymerase II. J. Biol. Chem. 272, 1885–1890 (1997).
Selby, C. P. & Sancar, A. Cockayne syndrome group B protein enhances elongation by RNA polymerase II. Proc. Natl Acad. Sci. USA 94, 11205–11209 (1997).
Newman, J. C., Bailey, A. D. & Weiner, A. M. Cockayne syndrome group B protein (CSB) plays a general role in chromatin maintenance and remodeling. Proc. Natl Acad. Sci. USA 103, 9613–9618 (2006).
Muftuoglu, M. et al. Cockayne syndrome group B protein has novel strand annealing and exchange activities. Nucleic Acids Res. 34, 295–304 (2006).
Frontini, M. & Proietti- De-Santis, L. Cockayne syndrome B protein (CSB): linking p53, HIF-1 and p300 to robustness, lifespan, cancer and cell fate decisions. Cell Cycle 8, 693–696 (2009).
Imam, S. Z. et al. Cockayne syndrome protein B interacts with and is phosphorylated by c-Abl tyrosine kinase. Nucleic Acids Res. 35, 4941–4951 (2007).
Thorsland, T. et al. Cooperation of the Cockayne syndrome group B protein and poly(ADP-ribose) polymerase I in the response to oxidative damage. Mol. Cell. Biol. 25, 7625–7636 (2005).
Mallery, D. L. et al. Molecular analysis of mutations in the CSB (ERCC6) gene in patients with Cockayne syndrome. Am. J. Hum. Genet. 62, 77–85 (1998).
Khobta, A., Kitsera, N., Speckmann, B. & Epe, B. 8-Oxoguanine DNA glycosylase (Ogg1) causes a transcriptional inactivation of damaged DNA in the absence of functional Cockayne syndrome B (Csb) protein. DNA Repair (Amst.) 8, 309–317 (2009).
Stevnsner, T. et al. Mitochondrial repair of 8-oxoguanine is deficient in Cockayne syndrome group B. Oncogene 21, 8675–8682 (2002).
Colella, S., Nardo, T., Botta, E., Lehmann, A. R. & Stefanini, M. Identical mutations in the CSB gene associated with either Cockayne syndrome or the DeSanctis–Cacchione variant of xeroderma pigmentosum. Hum. Mol. Genet. 9, 1171–1175 (2000).
Horibata, K. et al. Complete absence of Cockayne syndrome group B gene product gives rise to UV-sensitive syndrome but not Cockayne syndrome. Proc. Natl Acad. Sci. USA 101, 15410–15415 (2004).
Laugel, V. et al. COFS syndrome: three additional cases with CSB mutations, new diagnostic criteria and an approach to investigation. J. Med. Genet. 45, 564–571 (2008).
Newman, J. C., Bailey, A. D., Fan, H. Y., Pavelitz, T. & Weiner, A. M. An abundant evolutionarily conserved CSB–PiggyBac fusion protein expressed in Cockayne syndrome. PLoS Genet. 4, e1000031 (2008).
Laugel, V. et al. Deletion of 5′ sequences of the CSB gene provides insight into the pathophysiology of Cockayne syndrome. Eur. J. Hum. Genet. 16, 320–327 (2008).
Nardo, T. et al. A UV-sensitive syndrome patient with a specific CSA mutation reveals separable roles for CSA in response to UV and oxidative DNA damage. Proc. Natl Acad. Sci. USA 106, 6209–6214 (2009).
Hayashi, M. et al. Oxidative stress and disturbed glutamate transport in hereditary nucleotide repair disorders. J. Neuropathol. Exp. Neurol. 60, 350–356 (2001).
Vuillaume, M. et al. Striking differences in cellular catalase activity between two DNA repair-deficient diseases: xeroderma pigmentosum and trichothiodystrophy. Carcinogenesis 13, 321–328 (1992).
Kuraoka, I. et al. RNA polymerase II bypasses 8-oxoguanine in the presence of transcription elongation factor TFIIS. DNA Repair (Amst.) 6, 841–851 (2007).
Kathe, S. D., Shen, G. P. & Wallace, S. S. Single-stranded breaks in DNA but not oxidative DNA base damages block transcriptional elongation by RNA polymerase II in HeLa cell nuclear extracts. J. Biol. Chem. 279, 18511–18520 (2004).
Brooks, P. J. The case for 8,5′-cyclopurine-2′-deoxynucleosides as endogenous DNA lesions that cause neurodegeneration in xeroderma pigmentosum. Neuroscience 145, 1407–1417 (2007).
Botta, E. et al. Analysis of mutations in the XPD gene in Italian patients with trichothiodystrophy: site of mutation correlates with repair deficiency, but gene dosage appears to determine clinical severity. Am. J. Hum. Genet. 63, 1036–1048 (1998).
Stefanini, M. et al. Genetic heterogeneity of the excision repair defect associated with trichothiodystrophy. Carcinogenesis 14, 1101–1105 (1993).
Cleaver, J. E. Splitting hairs — discovery of a new DNA repair and transcription factor for the human disease trichothiodystrophy. DNA Repair 4, 285–287 (2005).
Vitorino, M. et al. Solution structure and self-association properties of the p8 TFIIH subunit responsible for trichothiodystrophy. J. Mol. Biol. 368, 473–480 (2007).
Kainov, D. E., Vitorino, M., Cavarelli, J., Poterszman, A. & Egly, J.-M. Structural basis for group A trichothiodystrophy. Nature Struct. Mol. Biol. 15, 980–984 (2008).
Taylor, E. M. et al. Xeroderma pigmentosum and trichothiodystrophy are associated with different mutations in the XPD (ERCC2) repair/transcription gene. Proc. Natl Acad. Sci. USA 94, 8658–8663 (1997).
Fan, L. et al. XPD helicase structures and activities: insights into the cancer and aging phenotypes from XPD mutations. Cell 133, 789–800 (2008).
Liu, H. et al. Structure of the DNA repair helicase XPD. Cell 133, 801–812 (2008).
Wolski, S. C. et al. Crystal structure of the FeS cluster-containing nucleotide excision repair helicase XPD. PLoS Biol. 6, 1332–1342 (2008). References 107–109 describe the crystal structures of three different archaean XPD homologues, which provide clues to the reasons why different mutations in the corresponding human protein can give rise to a wide range of clinical disorders through different changes of function.
Dubaele, S. et al. Basal transcription defect discriminates between xeroderma pigmentosum and trichothiodystrophy in XPD patients. Mol. Cell 11, 1635–1646 (2003).
Koonin, E. V. Escherichia coli dinG gene encodes a putative DNA helicase related to a group of eukaryotic helicases including Rad3 protein. Nucleic Acids Res. 21, 1497–1503 (1993).
Coin, F. et al. Mutations in the XPD helicase gene result in XP and TTD phenotypes, preventing interaction between XPD and the p44 subunit of TFIIH. Nature Genet. 20, 184–188 (1998).
Chen, D. et al. Activation of estrogen receptor α by S118 phosphorylation involves a ligand-dependent interaction with TFIIH and participation of CDK7. Mol. Cell 6, 127–137 (2000).
Keriel, A., Stary, A., Sarasin, A., Rochette-Egly, C. & Egly, J.-M. XPD mutations prevent TFIIH-dependent transactivation by nuclear receptors and phosphorylation of RARa. Cell 109, 125–135 (2002).
Compe, E. et al. Dysregulation of the peroxisome proliferator-activated receptor target genes by XPD mutations. Mol. Cell. Biol. 25, 6065–6076 (2005).
Ito, S. et al. XPG stabilizes TFIIH, allowing transactivation of nuclear receptors: implications for Cockayne syndrome in XP-G/CS patients. Mol. Cell 26, 231–243 (2007).
Boyle, J. et al. Persistence of repair proteins at unrepaired DNA damage distinguishes diseases with ERCC2 (XPD) mutations: cancer-prone xeroderma pigmentosum vs. non-cancer-prone trichothiodystrophy. Hum. Mutat. 29, 1194–1208 (2008).
Vermeulen, W. et al. A temperature-sensitive disorder in basal transcription and DNA repair in humans. Nature Genet. 27, 299–303 (2001).
Berneburg, M. & Lehmann, A. R. Xeroderma pigmentosum and related disorders: defects in DNA repair and transcription. Adv. Genet. 43, 71–102 (2001).
Broughton, B. C. et al. Two individuals with features of both xeroderma pigmentosum and trichothiodystrophy highlight the complexity of the clinical outcomes of mutations in the XPD gene. Hum. Mol. Genet. 10, 2539–2547 (2001).
Fujimoto, M. et al. Two new XPD patients compound heterozygous for the same mutation demonstrate diverse clinical features. J. Invest. Dermatol. 125, 86–92 (2005).
Alekseev, S. et al. Enhanced DDB2 expression protects mice from carcinogenic effects of chronic UV-B irradiation. Cancer Res. 65, 10298–10306 (2005).
Gorgels, T. G. et al. Retinal degeneration and ionizing radiation hypersensitivity in a mouse model for Cockayne syndrome. Mol. Cell. Biol. 27, 1433–1441 (2007).
van der Pluijm, I. et al. Impaired genome maintenance suppresses the growth hormone–insulin-like growth factor 1 axis in mice with Cockayne syndrome. PLoS Biol. 5, e2 (2006).
Susa, D. et al. Congenital DNA repair deficiency results in protection against renal ischemia reperfusion injury in mice. Aging Cell 8, 192–200 (2009).
Szabó, C. Roles of poly(ADP-ribose) polymerase activation in the pathogenesis of diabetes mellitus and its complications. Pharmacol. Res. 52, 60–71 (2005).
Robbins, J. H., Brumback, R. A. & Moshell, A. N. Clinically asymptomatic xeroderma pigmentosum neurological disease in an adult: evidence for a neurodegeneration in later life caused by defective DNA repair. Eur. Neurol. 33, 188–190 (1993).
Dizdaroglu, M. & Teebor, G. W. Targeted deletion of the genes encoding NTH1 and NEIL1 DNA N-glycosylases reveals the existence of novel carcinogenic oxidative damage to DNA. DNA Repair (Amst.) 8, 786–794 (2009).
Klungland, A. & Bjelland, S. Oxidative damage to purines in DNA: role of mammalian Ogg1. DNA Repair (Amst.) 6, 481–488 (2007).
Laposa, R. R., Feeney, L., Crowley, E., de Feraudy, S. & Cleaver, J. E. p53 suppression overwhelms DNA polymerase h deficiency in determining the cellular UV DNA damage response. DNA Repair 6, 1794–1804 (2007).
Gueven, N. et al. Dramatic extension of tumor latency and correction of neurobehavioral phenotype in Atm-mutant mice with a nitroxide antioxidant. Free Radic. Biol. Med. 41, 992–1000 (2006).
Reardon, J. T. & Sancar, A. Nucleotide excision repair. Prog. Nucleic Acid Res. Mol. Biol. 79, 183–235 (2005). This is an extensive review of the biochemistry of NER with special emphasis on the mechanisms by which proteins of low inherent affinity can have specificity in detecting and binding to damaged DNA.
Cleaver, J. E. & Mitchell, D. L. in Cancer Medicine Vol. 1 Ch. 17 (eds Kufe, D. W. et al.) 283–291 (BC Deckker, Ontario, 2006).
Wang, Y. et al. Evidence of ultraviolet type mutations in xeroderma pigmentosum melanomas. Proc. Natl Acad. Sci. USA 106, 6279–6284 (2009).
Suarez, H. G. et al. Activated oncogenes in human skin tumors from a repair-deficient syndrome, xeroderma pigmentosum. Cancer Res. 49, 1223–1228 (1989).
Giglia, G. et al. p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group C. Cancer Res. 58, 4402–4409 (1998).
Bodak, N. et al. High levels of patched gene mutations in basal-cell carcinomas from patients with xeroderma pigmentosum. Proc. Natl Acad. Sci. USA 96, 5117–5122 (1999).
Niedernhofer, L. J. et al. A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis. Nature 444, 1038–1043 (2006).
Yang, L. J., Jiang, H. & Rangel, K. M. RNA polymerase II stalled on a DNA template during transcription elongation is ubiquitinated and the ubiquitination facilitates displacement of the elongation complex. Int. J. Oncol. 22, 683–689 (2003).
Sugasawa, K. et al. Xeroderma pigmentosum group C protein complex is the initiator of global nucleotide excision repair. Mol. Cell 2, 223–232 (1998).
Wakasugi, M. & Sancar, A. Assembly, subunit composition, and footprint of human DNA repair excision nuclease. Proc. Natl Acad. Sci. USA 95, 6669–6674 (1998).
Oh, K. S., Imoto, K., Boyle, J., Khan, S. G. & Kraemer, K. H. Influence of XPB helicase on recruitment and redistribution of nucleotide excision repair proteins at sites of UV-induced DNA damage. DNA Repair (Amst.) 6, 1359–1370 (2007).
Evans, E., Moggs, J. G., Hwang, J. R., Egly, J.-M. & Wood, R. M. Mechanism of open complex formation by human nucleotide excision repair factors. EMBO J. 16, 6559–6573 (1997).
Coin, F., Oksenych, V. & Egly, J.-M. Distinct roles for the XPB/p52 and XPD/p44 subcomplexes of TFIIH in damaged DNA opening during nucleotide excision repair. Mol. Cell 26, 245–256 (2007).
Staresincic, L. et al. Coordination of dual incision and repair synthesis in human nucleotide excision repair. EMBO J. 28, 1111–1120 (2009).
Ogi, T. & Lehmann, A. The Y-family DNA polymerase κ (pol κ) functions in mammalian nucleotide-excision repair. Nature Cell Biol. 8, 640–642 (2006).
Moser, J. et al. Sealing of chromosomal DNA nicks during nucleotide excision repair requires XRCC1 and DNA ligase III α in a cell-cycle-specific manner. Mol. Cell 27, 311–323 (2007).
Scharer, O. D. Achieving broad substrate specificity in damage recognition by binding to accessible nondamaged DNA. Cell 28, 184–186 (2007). This paper describes the ribbon structure of the DNA-binding region of yeast Rad4 and shows that the mechanism of damage recognition involves the extrusion of the damaged site to an extrahelical position.
The work described here was supported by grant 1R01NS052781 from the US National Institute of Neurological Disorders and Stroke. We are also grateful to the XP Society, the XP Family Support Group and the Luke O'Brien Foundation for their continued support and encouragement.
A group of single-celled microorganisms that lack a nucleus or any other organelles. They have an independent evolutionary history, show distinctive biochemistry and are now classified as a separate domain from eukaryotes and bacteria.
- Cachectic dwarfism
Dwarfism associated with loss of weight, muscle atrophy, fatigue, weakness and substantial loss of appetite. Cachexia is the loss of body mass that cannot be reversed nutritionally even with caloric supplements.
Non-inflammatory damage to the retina of the eye. Frequently, retinopathy is an ocular manifestation of systemic disease.
A neurodevelopmental disorder in which the circumference of the head is more than two standard deviations smaller than average for the person's age and sex.
- Purkinje cells
The primary integrative neurons of, and sole output from, the cerebellar cortex. The cerebellum has an important role in the integration of sensory perception, coordination and motor control.
A heterogeneous family of skin disorders characterized by dry, thickened, scaly or flaky skin. The term arises from a resemblance to the scales on a fish.
- Cyclobutane pyrimidine dimer
The most common photoproduct induced in DNA by shortwave UV-B and UV-C wavelengths. Adjacent pyrimidines on the same DNA strand are linked by new bonds between the 5–5 and 6–6 positions and the normal 5=6 double bonds become single.
The conjugation of ubiquitin, which is a highly conserved 76-amino-acid protein, to another protein. Monoubiquitylation is involved in cell signalling, whereas polyubiquitylation can mark proteins for destruction.
- [6–4] photoproduct
An ultraviolet radiation-induced DNA lesion formed between the C-4 position of a 5′ pyrimidine and the C-6 position of an adjacent pyrimidine. This occurs approximately one-third as frequently as the cyclobutane pyrimidine dimer but causes greater structural distortion.
- SWI/SNF proteins
(Switch/sucrose non-fermentable proteins). Chromatin remodelling multiprotein complexes. This protein family was initially identified in yeast, but related complexes exist in mammals and are involved in gene activation and repression.
A post-translational modification that involves the addition of one or more ADP-ribose moieties to proteins. It is involved in cell signalling and the control of many processes, including DNA repair and apoptosis. The modification generally results in reduced protein activity.
- Base excision repair
A process for replacing damaged single nucleotides that involves DNA glycosylases.
- Reactive oxygen species
Ions or small molecules, including oxygen ions, free radicals and inorganic and organic peroxides, that are highly reactive owing to the presence of unpaired valence shell electrons. They are a by-product of the normal metabolism of oxygen and have important roles in cell signalling. Increased levels, due to environmental stress, can result in damage to cells.
A mobile DNA element that can move in the genome. Transposons can be used for various applications, including insertional mutagenesis, gene identification, gene tagging and DNA sequencing.
- Glycation end product
The product of a chain of chemical reactions after an initial glycation reaction by which sugar molecules become bound to a protein or lipid molecule without the controlling action of an enzyme.
- Globus pallidus
A subcortical structure of the brain that is a major element of the basal ganglia system.
An enzyme that separates the two nucleic acid strands in a double helix, which results in the formation of regions of ssDNA or ssRNA.
- Ischaemia–reperfusion injury
Injury to the epithelial cells of blood vessels and surrounding tissue that occurs during reoxygenation after the transient interruption of blood flow. It is thought to be caused by the rapid changes in tissue oxygenation.
DNA glycosylases are a family of enzymes that are involved in base excision repair. They remove the damaged nitrogenous base by flipping it out of the double helix. This is followed by cleavage of the N-glycosidic bond. The sugar–phosphate backbone remains intact, creating an apurinic or apyrimidinic site.
About this article
Cite this article
Cleaver, J., Lam, E. & Revet, I. Disorders of nucleotide excision repair: the genetic and molecular basis of heterogeneity. Nat Rev Genet 10, 756–768 (2009). https://doi.org/10.1038/nrg2663
Biomarker Research (2020)
Biomarker Research (2020)
Nature Communications (2020)
Continuous transcription initiation guarantees robust repair of all transcribed genes and regulatory regions
Nature Communications (2020)
Multimodal imaging in a family with Cockayne syndrome with a novel pathogenic mutation in the ERCC8 gene, and significant phenotypic variability
Documenta Ophthalmologica (2020)